Literature DB >> 20029815

Emergence of new norovirus variants and genetic heterogeneity of noroviruses and sapoviruses in children admitted to hospital with diarrhea in Thailand.

Pattara Khamrin1, Niwat Maneekarn, Aksara Thongprachum, Natthawan Chaimongkol, Shoko Okitsu, Hiroshi Ushijima.   

Abstract

Enteric caliciviruses, including noroviruses (NoVs) and sapoviruses (SaVs), are recognized as important etiologic agents of acute gastroenteritis with considerable genetic diversity. In this study, fecal specimens collected from 147 infants and young children admitted to hospital with acute gastroenteritis in 2005 in Chiang Mai, Thailand, were screened for NoVs and SaVs by reverse transcription-multiplex polymerase chain reaction (RT-multiplex PCR). Ten isolates (6.8%) belonged to NoV GII genogroup and five (3.4%) were positive for SaVs. GII/4 was the most predominant genotype of NoVs, followed by GII/15, GII/6, and GII/12. Surprisingly, NoVs GII/1, GII/2, GII/3, GII/7, and GII/16 genotypes, which were detected previously during the 2002-2004 survey, were not detected in 2005. Conversely, NoVs GII/6, GII/12, and GII/15 appeared in 2005 but were not detected during the 2002-2004 survey. The only genotype found to be common, as the most predominant genotype, in both surveys was NoV GII/4. Similar findings were also observed for SaVs, that is, the GI/2 and GIV detected during 2002-2004 were not detected in 2005, while GI/5 and GII/3 detected in 2005 were not detected previously during the 2002-2004 surveillance. In addition, comprehensive genetic evolutionary analysis of NoV GII/4 genotype demonstrated that the majority of GII/4 detected in this study (CMH002/05, CMH005/05, CMH042/05, and CMH083/05) were classified as new NoV variants and fell into subtype GII/4-d (Hunter'04-like cluster). Only one NoV GII/4 strain (CMH142/05) belonged to subtype GII/4-e. The data indicated heterogeneity and highly dynamic genotypic distribution of NoVs and SaVs circulating in children admitted to hospital with acute gastroenteritis in Chiang Mai, Thailand. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20029815     DOI: 10.1002/jmv.21640

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Detection and molecular characterization of cosavirus in adults with diarrhea, Thailand.

Authors:  Pattara Khamrin; Natthawan Chaimongkol; Rungnapa Malasao; Boonpa Suantai; Wilaiporn Saikhruang; Tipachan Kongsricharoern; Nuthapong Ukarapol; Shoko Okitsu; Hiroyuki Shimizu; Satoshi Hayakawa; Hiroshi Ushijima; Niwat Maneekarn
Journal:  Virus Genes       Date:  2011-12-16       Impact factor: 2.332

2.  Occurrence of Norovirus GIV in Environmental Water Samples from Belém City, Amazon Region, Brazil.

Authors:  Dielle Monteiro Teixeira; Juliana Merces Hernandez; Luciana Damascena Silva; Darleise de Souza Oliveira; Paula Katharine de Pontes Spada; Tereza Cristina Monteiro Gurjão; Joana D'Arc Pereira Mascarenhas; Alexandre Costa Linhares; Lena Líllian Canto de Sá Morais; Yvone Benchimol Gabbay
Journal:  Food Environ Virol       Date:  2015-11-04       Impact factor: 2.778

3.  Epidemiological profile and genetic diversity of sapoviruses (SaVs) identified in children suffering from acute gastroenteritis in Pune, Maharashtra, Western India, 2007-2011.

Authors:  N Lasure; V Gopalkrishna
Journal:  Epidemiol Infect       Date:  2016-09-09       Impact factor: 4.434

4.  Acute gastroenteritis and enteric viruses in hospitalised children in southern Brazil: aetiology, seasonality and clinical outcomes.

Authors:  Sonia Maria Raboni; Guilherme Augusto Costa Damasio; Carla E O Ferreira; Luciane A Pereira; Meri B Nogueira; Luine R Vidal; Cristina R Cruz; Sergio M Almeida
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-07       Impact factor: 2.743

Review 5.  Prevalence of Human Sapovirus in Low and Middle Income Countries.

Authors:  Mpho Magwalivha; Jean-Pierre Kabue; Afsatou Ndama Traore; Natasha Potgieter
Journal:  Adv Virol       Date:  2018-09-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.